Presentation TVT 2012 Design and Function/Clinical Outcomes - Sapien 3 Presenter: Josep Rodes-Cabau June 03, 2012 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TVT 2012 Up Next Presentation TVT 2012 MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies Presenter: Jonathon Leipsic June 03, 2012 More slides + Presentation TVT 2012 Should CRT Be Considered Frontline Treatment for Functional Mitral Regurgitation (MR)? Presenter: Tasneem Naqvi June 04, 2012 Presentation TVT 2012 Percutaneous 'Large Hole' Vascular Access-Closure Devices Presenter: Martin Leon June 04, 2012 We Recommend
Presentation TVT 2012 MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies Presenter: Jonathon Leipsic June 03, 2012
Presentation TVT 2012 Should CRT Be Considered Frontline Treatment for Functional Mitral Regurgitation (MR)? Presenter: Tasneem Naqvi June 04, 2012
Presentation TVT 2012 Percutaneous 'Large Hole' Vascular Access-Closure Devices Presenter: Martin Leon June 04, 2012